Barosense
BaroSense develops minimally-invasive therapeutic weight loss procedures, devices and surgical treatments for the obese.
Employees
Enterprise value
$108—162m
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor | €0.0 | round | |
| investor investor investor investor | €0.0 | round | |
| investor investor investor investor investor investor | €0.0 | round | |
| investor investor investor investor investor investor investor investor | €0.0 | round | |
N/A | Acquisition | ||
| Total Funding | 000k | ||
Delphi Ventures(exited)
Invesco(exited)
Frazier Healthcare Partners(exited)
Pappas Capital(exited)
Synergy Life Science Partner(exited)
Inovia Capital(exited)
RWI Ventures(exited)
Synecor(exited)
RWI Group(exited)
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads